Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia.
Bankar A, Siriwardena TP, Rizoska B, Rydergård C, Kylefjord H, Rraklli V, Eneroth A, Pinho P, Norin S, Bylund J, Moses S, Bethell R, Kavanagh S, Maclean N, Gronda M, Wang X, Hurren R, Minden MD, Targett-Adams P, Schimmer AD, Albertella M. Bankar A, et al. Haematologica. 2021 Feb 1;106(2):574-579. doi: 10.3324/haematol.2019.226795. Haematologica. 2021. PMID: 31857370 Free PMC article. No abstract available.
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.
Perusini MA, Andrews C, Atenafu EG, Gupta V, Maze D, Schuh AC, Yee KW, Bankar A, Davidson MB, Richard-Carpentier G, Chan SM, Sibai J, Schimmer AD, Minden MD, Sibai H. Perusini MA, et al. Among authors: bankar a. Hematology. 2024 Dec;29(1):2329027. doi: 10.1080/16078454.2024.2329027. Epub 2024 Mar 25. Hematology. 2024. PMID: 38526239 Free article.
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitor.
England JT, Atenafu EG, Kennedy JA, Goraya B, Cheung V, Nye T, Gauthier K, Davidson MB, Bankar A, Sibai H, Maze D, Viswabandya A, Gupta V. England JT, et al. Among authors: bankar a. Am J Hematol. 2023 May;98(5):E127-E129. doi: 10.1002/ajh.26890. Epub 2023 Mar 7. Am J Hematol. 2023. PMID: 36814403 Free article. No abstract available.
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.
Smith E, Huang J, Viswabandya A, Maze D, Malik S, Cheung V, Siddiq N, Claudio J, Arruda A, Kennedy J, Bankar A, Law AD, Lam W, Michelis FV, Kim D, Lipton J, Kumar R, Mattsson J, McNamara C, Sibai H, Xu W, Gupta V. Smith E, et al. Among authors: bankar a. Transplant Cell Ther. 2021 Jul;27(7):600.e1-600.e8. doi: 10.1016/j.jtct.2021.03.027. Epub 2021 Mar 30. Transplant Cell Ther. 2021. PMID: 33798769 Free article.
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort.
England JT, McNamara CJ, Kennedy JA, Capo-Chichi JM, Huang J, Arruda A, Nye T, Cheung V, Claudio JO, Maze D, Sibai H, Tierens A, Tsui H, Bankar A, Xu W, Stockley T, Gupta V. England JT, et al. Among authors: bankar a. Leukemia. 2022 Jun;36(6):1689-1692. doi: 10.1038/s41375-022-01544-x. Epub 2022 Mar 26. Leukemia. 2022. PMID: 35347238 Free PMC article. No abstract available.
39 results